Æterna Zentaris Kurs/ Buchwert
Was ist das Kurs/ Buchwert von Æterna Zentaris?
Kurs/ Buchwert von Æterna Zentaris, Inc. ist 0.99
Was ist die Definition von Kurs/ Buchwert?
Kurs-Buchwert-Verhältnis repräsentiert das Verhältnis zwischen dem Aktienwert eines Unternehmens und dem Buchwert pro Aktie.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Kurs/ Buchwert von Unternehmen in Health Care Sektor auf TSX im Vergleich zu Æterna Zentaris
Was macht Æterna Zentaris?
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications. The company markets macimorelin under the Macrilen brand name. Aeterna Zentaris Inc. has a license agreement with University Wuerzburg to research, develop, manufacture, and sell a potential COVID-19 vaccine; development, manufacture, and commercialization of the treatment for neuromyelitis optica spectrum disorder; and to develop human 3D intestinal tissue models to study infection biology; and for pre-clinical development towards the potential treatment of Parkinson's disease. It also has a license agreement with Consilient Health Ltd., Novo Nordisk Novo Nordisk Health Care AG, and NK MEDITECH Ltd. for the development and commercialization of macimorelin in the United States and Canada, as well as The University of Sheffield, the United Kingdom for the research, development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of primary hypoparathyroidism. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina.
Unternehmen mit kurs/ buchwert ähnlich Æterna Zentaris
- One Media iP Plc hat Kurs/ Buchwert von 0.99
- FS Bancorp Inc hat Kurs/ Buchwert von 0.99
- BOK hat Kurs/ Buchwert von 0.99
- Cielo SA hat Kurs/ Buchwert von 0.99
- Kelt Exploration hat Kurs/ Buchwert von 0.99
- Corep Lighting hat Kurs/ Buchwert von 0.99
- Æterna Zentaris hat Kurs/ Buchwert von 0.99
- C.P. Pokphand Co hat Kurs/ Buchwert von 0.99
- Hathway Cable and Datacom hat Kurs/ Buchwert von 0.99
- Delta Resources hat Kurs/ Buchwert von 0.99
- Investor B (Fria) O.N hat Kurs/ Buchwert von 0.99
- Nuveen California Select Tax-Free Income Portfolio hat Kurs/ Buchwert von 0.99
- Jde Peets N.V hat Kurs/ Buchwert von 0.99